Items where Author is "Bazhin, A. V."

Article

(2024) TIM-3/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60 and THP-1. Bmc Cancer. p. 15.

(2023) PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia. Bmc Cancer. p. 9.

(2023) TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines. Frontiers in Immunology. p. 15. ISSN 1664-3224

(2022) Cancer Vaccine in Cold Tumors: Clinical Landscape, Challenges, and Opportunities. CURRENT CANCER DRUG TARGETS. pp. 437-453. ISSN 1568-0096 1873-5576 J9 - CURR CANCER DRUG TAR

(2022) Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy. FRONTIERS IN ONCOLOGY. ISSN 2234-943X J9 - FRONT ONCOL

(2021) The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies. FRONTIERS IN ONCOLOGY. ISSN 2234-943X J9 - FRONT ONCOL

(2021) mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients. VACCINES. ISSN 2076-393X J9 - VACCINES-BASEL

(2020) The Role of TIM-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy? Frontiers in Oncology. ISSN 2234-943X